Clinical Trials on Formulations for the Treatment of Wound Healing -recent Perspectives

Wounds can result from a variety of causes, including burns, traumas, surgeries, and long-term conditions like diabetes. The development of biofilms has detrimental consequences as well. Wound healing is also impacted by ageing, hypertrophic scarring, and recurrent injuries. With rising death rates and related costs, wound healing is a serious global concern. The severity of wound healing is caused by microbial infection, inflammation, and a lack of cell migration, proliferation, and angiogenesis. The many phases of wound healing include hemostasis, inflammation, proliferation, and remodeling to restore the integrity of the skin and subcutaneous tissue with its anti-microbial, anti-angiogenic, and anti-inflammatory effects. The development of biomaterials for wound dressings has reached a new benchmark and improved understanding. The extraordinary outcomes are caused by more recent discoveries and patents that concentrate on the wound microenvironments, such as pH, temperature, and reactive oxygen species. Because they can adjust to the current microenvironment at the injured surface, wound dressing materials that can function as theranostics also have significant advantages. The wound healing products should concentrate on cell-cell interactions, cell proliferation, cell signaling, and vascularization in order to make the therapy effective. The main advantages are also explained by the wound-healing material's penetrating effect. This review endeavored to throw light on different aspects of wounds and the latest advances in bioproducts effective for wound healing. Further, the clinical trials for wound healing products have been addressed.